Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Dis Markers
2022 Jan 01;2022:7571066. doi: 10.1155/2022/7571066.
Show Gene links
Show Anatomy links
Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies.
Shao T
,
Jiang X
,
Bao G
,
Li C
,
Guo C
.
???displayArticle.abstract???
Mitosis and spindle assembly require the microtubule-associated protein Xenopus kinesin-like protein 2 (TPX2). Although TPX2 is highly expressed in several malignant tumor forms, little is known about its role in cancer. In this study, we performed the gene set enrichment analysis of TPX2 in 33 types of cancers and an extensive pan-cancer bioinformatic analysis using prognosis, tumor mutational burdens, microsatellite instability, tumor microenvironment, and immune cell infiltration data. According to the differential expression study, TPX2 was found to be overexpressed across all studied cancer types. Based on the survival analysis, increased TPX2 expression was associated with a poor prognosis for most cancers. The TPX2 expression level was confirmed to correlate with the clinical stage, microsatellite instability, and tumor mutational burden across all cancer types. Furthermore, TPX2 expression has been linked to tumor microenvironments and immune cell infiltration, particularly in bladder urothelial carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, stomach adenocarcinoma, and uterine corpus endometrial carcinoma. Finally, the gene set enrichment analysis implicated TPX2 in the regulation of aminoacyl tRNA biosynthesis, which is the most important tumor cell cycle signaling pathway. This comprehensive pan-cancer analysis shows that TPX2 is a prognostic molecular biomarker for most cancers and suggests its potential as an effective therapeutic target for the treatment of these diseases.
Alfaro-Aco,
How TPX2 helps microtubules branch out.
2017, Pubmed,
Xenbase
Alfaro-Aco,
How TPX2 helps microtubules branch out.
2017,
Pubmed
,
Xenbase
Aran,
Systematic pan-cancer analysis of tumour purity.
2015,
Pubmed
Bayliss,
Determinants for Aurora-A activation and Aurora-B discrimination by TPX2.
2004,
Pubmed
,
Xenbase
Chen,
TPX2 in human clear cell renal carcinoma: Expression, function and prognostic significance.
2016,
Pubmed
,
Xenbase
Chen,
Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.
2018,
Pubmed
,
Xenbase
Cheng,
Two novel qualitative transcriptional signatures robustly applicable to non-research-oriented colorectal cancer samples with low-quality RNA.
2021,
Pubmed
Cui,
RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA.
2021,
Pubmed
Dvořák Tomaštíková,
Functional Divergence of Microtubule-Associated TPX2 Family Members in Arabidopsis thaliana.
2020,
Pubmed
Fishel,
The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.
2001,
Pubmed
Goldman,
Visualizing and interpreting cancer genomics data via the Xena platform.
2020,
Pubmed
Gomes-Filho,
Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
2020,
Pubmed
Gruss,
Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells.
2002,
Pubmed
,
Xenbase
Gruss,
Ran induces spindle assembly by reversing the inhibitory effect of importin alpha on TPX2 activity.
2001,
Pubmed
,
Xenbase
Heidebrecht,
p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M.
1997,
Pubmed
Jiang,
TPX2 regulates tumor growth in human cervical carcinoma cells.
2014,
Pubmed
,
Xenbase
Jiang,
TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
2019,
Pubmed
,
Xenbase
Li,
HnRNP-F promotes cell proliferation by regulating TPX2 in bladder cancer.
2019,
Pubmed
,
Xenbase
Liang,
TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.
2015,
Pubmed
Liu,
TPX2 siRNA regulates growth and invasion of esophageal cancer cells.
2014,
Pubmed
Long,
CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells.
2020,
Pubmed
,
Xenbase
Ma,
TPX2 promotes cell proliferation and migration via PLK1 in OC.
2018,
Pubmed
,
Xenbase
Ognibene,
Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy.
2019,
Pubmed
Petry,
Branching microtubule nucleation in Xenopus egg extracts mediated by augmin and TPX2.
2013,
Pubmed
,
Xenbase
Reid,
Suppression of microtubule assembly kinetics by the mitotic protein TPX2.
2016,
Pubmed
Rintala,
A systematic comparison of data- and knowledge-driven approaches to disease subtype discovery.
2021,
Pubmed
Roostalu,
Complementary activities of TPX2 and chTOG constitute an efficient importin-regulated microtubule nucleation module.
2015,
Pubmed
Samstein,
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
2019,
Pubmed
Subramanian,
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
2005,
Pubmed
Sui,
Prognostic significance of TPX2 and NIBP in esophageal cancer.
2019,
Pubmed
,
Xenbase
Taherdangkoo,
miR-485-3p suppresses colorectal cancer via targeting TPX2.
2020,
Pubmed
Thorsson,
The Immune Landscape of Cancer.
2018,
Pubmed
Wadsworth,
TPX2.
2015,
Pubmed
Wang,
CDK5-mediated phosphorylation and stabilization of TPX2 promotes hepatocellular tumorigenesis.
2019,
Pubmed
Wang,
miR-548a-3p Weakens the Tumorigenesis of Colon Cancer Through Targeting TPX2.
2022,
Pubmed
Wang,
The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
2020,
Pubmed
,
Xenbase
Wang,
Transcriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration.
2018,
Pubmed
Wei,
TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer.
2013,
Pubmed
Wittmann,
TPX2, A novel xenopus MAP involved in spindle pole organization.
2000,
Pubmed
,
Xenbase
Wittmann,
Localization of the kinesin-like protein Xklp2 to spindle poles requires a leucine zipper, a microtubule-associated protein, and dynein.
1998,
Pubmed
,
Xenbase
Yan,
TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.
2018,
Pubmed
,
Xenbase
Yang,
TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
2014,
Pubmed
,
Xenbase
Zhang,
TPX2 mediates prostate cancer epithelial-mesenchymal transition through CDK1 regulated phosphorylation of ERK/GSK3β/SNAIL pathway.
2021,
Pubmed
Zhong,
HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2.
2021,
Pubmed
Zhou,
TPX2 Enhanced the Activation of the HGF/ETS-1 Pathway and Increased the Invasion of Endocrine-Independent Prostate Carcinoma Cells.
2021,
Pubmed
Zhou,
TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer.
2020,
Pubmed
Zou,
TPX2 level correlates with cholangiocarcinoma cell proliferation, apoptosis, and EMT.
2018,
Pubmed
,
Xenbase
